SCHEMBL2643880

SCHEMBL2643880

CCCCC(NNOC(=O)C(F)(F)F)c1ccc(C(=O)OCC)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK1 Q15118 1/20 0.40
PDK2 Q15119 1/20 0.40
PDK3 Q15120 1/20 0.40
PDK4 Q16654 1/20 0.40
ESR1 P03372 2/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
ESR2 Q92731 1/20 0.39
CA14 Q9ULX7 1/20 0.39
CYP3A4 P08684 3/20 0.38
LMNA P02545 3/20 0.38
CYP1A2 P05177 2/20 0.38
MAOA P21397 1/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
TSHR P16473 3/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2642919 0.82 NAMPT (0.45) PDK1PDK2PDK3PDK4ESR1
SCHEMBL2643045 0.82 NAMPT (0.45) PDK1PDK2PDK3PDK4ESR1
Trifluoroacetic Acid SCHEMBL2643875 0.81 DPP4 (0.47) PDK1PDK2PDK3PDK4ESR1
SCHEMBL2643030 0.80 ESR1 (0.49) ESR1CA12CA1CA2CA7
SCHEMBL2662131 0.78 LMNA (0.51) ESR1CA12CA1CA2CA7
SCHEMBL2643017 0.76 ESR1 (0.43) PDK1PDK2PDK3PDK4ESR1
SCHEMBL2662885 0.68 CA1 (0.49) PDK1PDK2PDK3PDK4ESR1
SCHEMBL2662884 0.68 CA1 (0.49) PDK1PDK2PDK3PDK4ESR1
SCHEMBL11251092 0.68 CASR (0.55) CA12CA9LMNAMEN1KMT2A
SCHEMBL12328653 0.68 NPC1 (0.47) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070088070-A1 Pyrazole derivatives, compositions containing such compounds and methods of use PARMEE EMMA R 2007-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070088070-A1 Pyrazole derivatives, compositions containing such compounds and methods of use PC, GOT2, PNLIP PDK1 108/4885PDK2 6/4885PDK3 24/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.